Antitumor activity in metastatic disease does not predict efficacy in the adjuvant setting

JAMA. 2012 Apr 4;307(13):1431-2. doi: 10.1001/jama.2012.410.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cetuximab
  • Colonic Neoplasms / drug therapy*
  • Female
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab